Display options
Cite
Bajwa WK, Rastegarpour A, Bajwa OA, et al. The management of catatonia in bipolar disorder with stimulants. Case Rep Psychiatry. 2015;2015:423025doi: 10.1155/2015/423025.
Bajwa, W. K., Rastegarpour, A., Bajwa, O. A., & Babbitt, J. (2015). The management of catatonia in bipolar disorder with stimulants. Case reports in psychiatry, 2015423025. https://doi.org/10.1155/2015/423025
Bajwa, Waheed K, et al. "The management of catatonia in bipolar disorder with stimulants." Case reports in psychiatry vol. 2015 (2015): 423025. doi: https://doi.org/10.1155/2015/423025
Bajwa WK, Rastegarpour A, Bajwa OA, Babbitt J. The management of catatonia in bipolar disorder with stimulants. Case Rep Psychiatry. 2015;2015:423025. doi: 10.1155/2015/423025. Epub 2015 Feb 19. PMID: 25789191; PMCID: PMC4350849.
Copy Download .nbib Format: NLM
Share it on

Case Rep Psychiatry. 2015;2015:423025. doi: 10.1155/2015/423025. Epub 2015 Feb 19.

The management of catatonia in bipolar disorder with stimulants.

Case reports in psychiatry

Waheed K Bajwa, Ali Rastegarpour, Omar A Bajwa, Jessica Babbitt

Affiliations

  1. Cary Behavioral Health P.C., 160 NE Maynard Road, Suite 200, Cary, NC 27513, USA.

PMID: 25789191 PMCID: PMC4350849 DOI: 10.1155/2015/423025

Abstract

Catatonia, while not a rare occurrence in bipolar disorder, has not been widely discussed in the literature. We present a case of a married Caucasian male with a history of bipolar disorder, exhibiting catatonia and experiencing difficulty in day-to-day functioning. He demonstrated impairment in cognition and an inability to organize simple activities of daily life. After exhausting a number of options for medical management, including benzodiazepines, atypical antipsychotics, and amantadine, he only displayed significant clinical improvement with the addition of a stimulant, methylphenidate. In time, the patient saw a complete return to normal functioning. The use of stimulants for catatonia in bipolar disorder may be an interesting and effective option for treatment. While this is not the first time this treatment has been suggested, there is very little data in support of it; our case confirms the discoveries of previous case reports.

References

  1. J Neuropsychiatry Clin Neurosci. 2014 Winter;26(1):E43 - PubMed
  2. Psychosomatics. 2010 Jan-Feb;51(1):74-6 - PubMed
  3. Schizophr Res. 2013 Oct;150(1):26-30 - PubMed
  4. Bipolar Disord. 2004 Apr;6(2):166-7 - PubMed
  5. Compr Psychiatry. 2003 Jul-Aug;44(4):263-9 - PubMed
  6. Biomed J. 2013 Jan-Feb;36(1):35-9 - PubMed
  7. J Clin Psychiatry. 1990 May;51(5):203-5 - PubMed
  8. J Affect Disord. 2004 Apr;79 Suppl 1:S3-8 - PubMed
  9. Chin Med J (Engl). 2014;127(19):3388 - PubMed
  10. Gen Hosp Psychiatry. 2006 Jul-Aug;28(4):364-5 - PubMed
  11. Psychosomatics. 2012 Sep-Oct;53(5):482-4 - PubMed
  12. Compr Psychiatry. 1998 Jan-Feb;39(1):35-46 - PubMed
  13. Case Rep Psychiatry. 2013;2013:503601 - PubMed
  14. Arch Gen Psychiatry. 1977 Oct;34(10):1223-5 - PubMed

Publication Types